JP2018523675A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018523675A5 JP2018523675A5 JP2018507672A JP2018507672A JP2018523675A5 JP 2018523675 A5 JP2018523675 A5 JP 2018523675A5 JP 2018507672 A JP2018507672 A JP 2018507672A JP 2018507672 A JP2018507672 A JP 2018507672A JP 2018523675 A5 JP2018523675 A5 JP 2018523675A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound
- pharmaceutical formulation
- streptococcus
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 206010060945 Bacterial infection Diseases 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 229940055033 Proteus mirabilis Drugs 0.000 claims 3
- 241000588770 Proteus mirabilis Species 0.000 claims 3
- 229940076185 Staphylococcus aureus Drugs 0.000 claims 3
- 241000191967 Staphylococcus aureus Species 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 150000003840 hydrochlorides Chemical class 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 241000588626 Acinetobacter baumannii Species 0.000 claims 2
- 241000589513 Burkholderia cepacia Species 0.000 claims 2
- 229940092559 Enterobacter aerogenes Drugs 0.000 claims 2
- 229940032049 Enterococcus faecalis Drugs 0.000 claims 2
- 241000194032 Enterococcus faecalis Species 0.000 claims 2
- 241000194031 Enterococcus faecium Species 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 229940023064 Escherichia coli Drugs 0.000 claims 2
- 229940047650 Haemophilus influenzae Drugs 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 241000588915 Klebsiella aerogenes Species 0.000 claims 2
- 229940045505 Klebsiella pneumoniae Drugs 0.000 claims 2
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 2
- 229940115932 Legionella pneumophila Drugs 0.000 claims 2
- 241000589242 Legionella pneumophila Species 0.000 claims 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 2
- 241000588655 Moraxella catarrhalis Species 0.000 claims 2
- 229940055023 Pseudomonas aeruginosa Drugs 0.000 claims 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- 241000607715 Serratia marcescens Species 0.000 claims 2
- 229940098362 Serratia marcescens Drugs 0.000 claims 2
- 241000122973 Stenotrophomonas maltophilia Species 0.000 claims 2
- 229940030998 Streptococcus agalactiae Drugs 0.000 claims 2
- 241000193985 Streptococcus agalactiae Species 0.000 claims 2
- 229940031000 Streptococcus pneumoniae Drugs 0.000 claims 2
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 2
- 229940076156 Streptococcus pyogenes Drugs 0.000 claims 2
- 241000193996 Streptococcus pyogenes Species 0.000 claims 2
- 206010046577 Urinary tract infection Diseases 0.000 claims 2
- 201000005661 acute cystitis Diseases 0.000 claims 2
- 229960003085 meticillin Drugs 0.000 claims 2
- 241000217846 Bacteroides caccae Species 0.000 claims 1
- 241000606124 Bacteroides fragilis Species 0.000 claims 1
- 241001135228 Bacteroides ovatus Species 0.000 claims 1
- 241000315377 Bremia ovata Species 0.000 claims 1
- 102100014408 CYBC1 Human genes 0.000 claims 1
- 108060002022 CYBC1 Proteins 0.000 claims 1
- 241000588923 Citrobacter Species 0.000 claims 1
- 210000003555 Cloaca Anatomy 0.000 claims 1
- 241000588914 Enterobacter Species 0.000 claims 1
- 229940119563 Enterobacter cloacae Drugs 0.000 claims 1
- 241000588697 Enterobacter cloacae Species 0.000 claims 1
- 241001505295 Eros Species 0.000 claims 1
- 241000588768 Providencia Species 0.000 claims 1
- 241000588777 Providencia rettgeri Species 0.000 claims 1
- 241000295644 Staphylococcaceae Species 0.000 claims 1
- 241000122971 Stenotrophomonas Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Claims (17)
- 塩酸塩の形態で存在する、請求項1に記載の化合物又は薬学的に許容されるその塩。
- 請求項1に記載の化合物又は薬学的に許容されるその塩、及び薬学的に許容される担体を含む、医薬製剤。
- リポソーム製剤として存在する、請求項3に記載の医薬製剤。
- 細菌感染症を治療するための、請求項3又は4に記載の医薬製剤。
- 細菌感染症が尿路感染症である、請求項5に記載の医薬製剤。
- 細菌感染症が、インフルエンザ菌(Haemophilus influenzae)、モラクセラ・カタラーリス(Moraxella catarrhalis)、アシネトバクター・バウマニ(Acinetobacter baumannii)、大腸菌(Escherichia coli)、緑膿菌(Pseudomonas aeruginosa)、プロテウス・ミラビリス(Proteus mirabilis)、レジオネラ・ニューモフィラ(Legionella pneumophila)、エンテロバクター・クロアカ(Enterobacter cloacae)、エンテロバクター・アエロゲネス(Enterobacter aerogenes)、肺炎桿菌(Klebsiella pneumoniae)、ステノトロフォモナス・マルトフィリア(Stenotrophomonas maltophilla)、サイトロバクター属の種(Citrobacter spp)、バークホルデリア・セパシア(Burkholderia cepacia)、セラチア・マルセッセンス(Serratia marcescens)、プロビデンシア・レットゲリ(Providencia rettgeri)、黄色ブドウ球菌(Staphylococcus aureus)、肺炎レンサ球菌(Streptococcus pneumoniae)、化膿レンサ球菌(Streptococcus pyogenes)、エンテロコッカス・フェカリス(Enterococcus faecalis)、ストレプトコッカス・アガラクティアエ(Streptococcus agalactiae)、エンテロコッカス・フェシウム(Enterococcus faecium)、メチシリン耐性黄色ブドウ球菌(MRSA)、バクテロイデス・フラギリス(Bacteroides fragilis)、B.カカエ(B. caccae)、B.オバタス(B. ovatus)及びB.テタイオタミクロン(B. thetaiotamicron)からなる群から選択される1種以上の生物体により引き起こされるものである、請求項5に記載の医薬製剤。
- 請求項8に記載の化合物又は薬学的に許容されるその塩、及び薬学的に許容される担体を含む、医薬製剤。
- リポソーム製剤として存在する、請求項9に記載の医薬製剤。
- 細菌感染症を治療するための、請求項9又は10に記載の医薬製剤。
- 請求項12に記載の化合物の塩酸塩、及び薬学的に許容される担体を含む、医薬製剤。
- リポソーム製剤として存在する、請求項13に記載の医薬製剤。
- 細菌感染症を治療するための、請求項13又は14に記載の医薬製剤。
- 細菌感染症が尿路感染症である、請求項15に記載の医薬製剤。
- 細菌感染症が、インフルエンザ菌、モラクセラ・カタラーリス、アシネトバクター・バウマニ、大腸菌、緑膿菌、プロテウス・ミラビリス、レジオネラ・ニューモフィラ、エンテロバクター・クロアカ、エンテロバクター・アエロゲネス、肺炎桿菌、ステノトロフォモナス・マルトフィリア、サイトロバクター属の種、バークホルデリア・セパシア、セラチア・マルセッセンス、プロビデンシア・レットゲリ、黄色ブドウ球菌、肺炎レンサ球菌、化膿レンサ球菌、エンテロコッカス・フェカリス、ストレプトコッカス・アガラクティアエ、エンテロコッカス・フェシウム、メチシリン耐性黄色ブドウ球菌(MRSA)、バクテロイデス・フラギリス、B.カカエ、B.オバタス及びB.テタイオタミクロンからなる群から選択される1種以上の生物体により引き起こされるものである、請求項15に記載の医薬製剤。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562205732P | 2015-08-16 | 2015-08-16 | |
US62/205,732 | 2015-08-16 | ||
US201662308928P | 2016-03-16 | 2016-03-16 | |
US62/308,928 | 2016-03-16 | ||
PCT/IB2016/054890 WO2017029602A2 (en) | 2015-08-16 | 2016-08-15 | Compounds for use in antibacterial applications |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018523675A JP2018523675A (ja) | 2018-08-23 |
JP2018523675A5 true JP2018523675A5 (ja) | 2019-09-26 |
JP6757402B2 JP6757402B2 (ja) | 2020-09-16 |
Family
ID=57218948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018507672A Expired - Fee Related JP6757402B2 (ja) | 2015-08-16 | 2016-08-15 | ピラジノ[2,3−b][1,4]オキサジン−3−オン又は関連する環系を含む抗菌剤 |
Country Status (22)
Country | Link |
---|---|
US (2) | US10364254B2 (ja) |
EP (1) | EP3334739A2 (ja) |
JP (1) | JP6757402B2 (ja) |
KR (1) | KR20180038046A (ja) |
CN (1) | CN108137616B (ja) |
AU (2) | AU2016307969C1 (ja) |
CA (1) | CA2995715A1 (ja) |
CL (1) | CL2018000403A1 (ja) |
CO (1) | CO2018002204A2 (ja) |
CR (1) | CR20180111A (ja) |
DO (1) | DOP2018000049A (ja) |
EA (1) | EA033314B1 (ja) |
HK (1) | HK1248680A1 (ja) |
IL (1) | IL257265B (ja) |
MA (1) | MA42621A (ja) |
MX (1) | MX2018002033A (ja) |
PE (1) | PE20181143A1 (ja) |
PH (1) | PH12018500358A1 (ja) |
TW (1) | TW201722965A (ja) |
UY (1) | UY36851A (ja) |
WO (1) | WO2017029602A2 (ja) |
ZA (1) | ZA201800722B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY36851A (es) * | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
WO2019180634A1 (en) | 2018-03-23 | 2019-09-26 | Glaxosmithkline Intellectual Property Development Limited | Synthesis of oxazinone-containing bicyclic aromatic and heteroaromatic aldehydes |
TW202116782A (zh) | 2019-07-16 | 2021-05-01 | 瑞士商愛杜西亞製藥有限公司 | 喹啉酮衍生物 |
CN111269247B (zh) * | 2020-03-04 | 2020-11-24 | 河南科技大学第一附属医院 | 具有抑制大肠杆菌作用的噻嗪酮药物分子的制备方法 |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4632671B1 (ja) * | 1969-10-13 | 1971-09-23 | Eisai Co Ltd | |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
GB2064336B (en) | 1979-12-06 | 1984-03-14 | Glaxo Group Ltd | Device for dispensing medicaments |
EP0069715B1 (en) | 1981-07-08 | 1986-11-05 | Aktiebolaget Draco | Powder inhalator |
US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
AU570013B2 (en) | 1982-10-08 | 1988-03-03 | Glaxo Group Limited | Medicament inhaler |
GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
CA1272917A (en) | 1985-07-30 | 1990-08-21 | Paul Kenneth Rand | Devices for administering medicaments to patients |
JPH0733379B2 (ja) * | 1986-06-27 | 1995-04-12 | エーザイ株式会社 | 光学活性α−トコフエロ−ルの製造方法 |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
SK280967B6 (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Inhalačný prístroj |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
IL115849A0 (en) | 1994-11-03 | 1996-01-31 | Merz & Co Gmbh & Co | Tangential filtration preparation of liposomal drugs and liposome product thereof |
GB9700226D0 (en) | 1997-01-08 | 1997-02-26 | Glaxo Group Ltd | Inhalation device |
US5827533A (en) | 1997-02-06 | 1998-10-27 | Duke University | Liposomes containing active agents aggregated with lipid surfactants |
FR2798656B1 (fr) | 1999-09-17 | 2004-12-17 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
PL364808A1 (en) | 2000-07-21 | 2004-12-13 | Ljudmila Petrovna Maljuk | Plate for a stand-up meal |
WO2002008224A1 (en) | 2000-07-26 | 2002-01-31 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
GB0031088D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
AU2002219175A1 (en) | 2000-12-21 | 2002-07-01 | Ciba Speciality Chemicals Holding Inc. | Crystalline forms of cerivastatin sodium |
GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0118238D0 (en) | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
WO2003064431A2 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
WO2003064421A1 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine derivatives |
US20060014786A1 (en) * | 2002-05-17 | 2006-01-19 | Rajeev Raut | Opthalmic pharmaceutical compositions and methods for treating ocular inflammation |
AR040336A1 (es) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
WO2004002990A2 (en) | 2002-06-27 | 2004-01-08 | F. Hoffmann-La Roche Ag | Synthesis of purine derivatives |
GB0217294D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
FR2844270B1 (fr) | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent |
FR2844268B1 (fr) | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent |
DE50312598D1 (de) | 2002-10-10 | 2010-05-20 | Morphochem Ag Komb Chemie | Neue verbindungen mit antibakterieller aktivität |
ATE461928T1 (de) | 2002-11-05 | 2010-04-15 | Glaxosmithkline Llc | Antibakterielle wirkstoffe |
JP4654035B2 (ja) | 2002-11-05 | 2011-03-16 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 抗菌剤 |
AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
TW200507841A (en) | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
FR2852954B1 (fr) | 2003-03-28 | 2006-07-14 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
DE10316081A1 (de) | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
FR2858619B1 (fr) | 2003-08-08 | 2006-12-22 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
US9214590B2 (en) | 2003-12-19 | 2015-12-15 | The University Of North Carolina At Chapel Hill | High fidelity nano-structures and arrays for photovoltaics and methods of making the same |
WO2005101466A2 (en) | 2003-12-19 | 2005-10-27 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
US8158728B2 (en) | 2004-02-13 | 2012-04-17 | The University Of North Carolina At Chapel Hill | Methods and materials for fabricating microfluidic devices |
FR2867472B1 (fr) | 2004-03-12 | 2008-07-18 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
US7691850B2 (en) | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
FR2872164B1 (fr) | 2004-06-29 | 2006-11-17 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
JP2008505920A (ja) | 2004-07-08 | 2008-02-28 | グラクソ グループ リミテッド | 抗菌剤 |
EP1773847A2 (en) * | 2004-07-09 | 2007-04-18 | Glaxo Group Limited | Antibacterial agents |
WO2006017326A1 (en) | 2004-07-13 | 2006-02-16 | Glaxo Group Limited | Antibacterial agents |
JP2008507543A (ja) | 2004-07-22 | 2008-03-13 | グラクソ グループ リミテッド | 抗細菌剤 |
DE602005024151D1 (de) | 2004-08-02 | 2010-11-25 | Glaxo Group Ltd | Antibakterielle mittel |
US20070161627A1 (en) | 2004-08-09 | 2007-07-12 | Miller William H | Antibacterial agents |
DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
WO2006032466A2 (en) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
WO2006038172A1 (en) | 2004-10-05 | 2006-04-13 | Actelion Pharmaceuticals Ltd | New piperidine antibiotics |
WO2006046552A1 (ja) | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
JP2008528598A (ja) * | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
US20090131444A1 (en) | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
WO2006137485A1 (ja) | 2005-06-24 | 2006-12-28 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
DOP2006000268A (es) | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
WO2007081876A2 (en) | 2006-01-04 | 2007-07-19 | Liquidia Technologies, Inc. | Nanostructured surfaces for biomedical/biomaterial applications and processes thereof |
CA2635205C (en) * | 2006-02-15 | 2014-06-10 | Actelion Pharmaceuticals Ltd | Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
KR101409261B1 (ko) | 2006-05-26 | 2014-06-18 | 다이쇼 세이야꾸 가부시끼가이샤 | 신규의 복소환 화합물 또는 그 염 및 그 중간체 |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
WO2008013952A2 (en) | 2006-07-27 | 2008-01-31 | The University Of North Carolina At Chapel Hill | Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells |
US8128393B2 (en) | 2006-12-04 | 2012-03-06 | Liquidia Technologies, Inc. | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom |
CL2007003693A1 (es) * | 2006-12-22 | 2008-06-27 | Actelion Pharmaceuticals Ltd | Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas. |
GB0707704D0 (en) * | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
WO2009024342A2 (en) * | 2007-08-23 | 2009-02-26 | Syngenta Participations Ag | Novel microbiocides |
US7976759B2 (en) | 2007-10-12 | 2011-07-12 | Liquidia Technologies, Inc. | System and method for producing particles and patterned films |
JP5620636B2 (ja) | 2007-11-26 | 2014-11-05 | 富山化学工業株式会社 | 新規な複素環化合物またはその塩を含有する抗菌剤 |
PT2344495E (pt) * | 2008-10-07 | 2015-04-01 | Actelion Pharmaceuticals Ltd | Compostos antibióticos de oxazolidinona tricíclica |
WO2010045987A1 (en) * | 2008-10-23 | 2010-04-29 | Glaxo Group Limited | Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials |
TW201022279A (en) * | 2008-11-14 | 2010-06-16 | Astrazeneca Ab | Chemical compounds |
MX366510B (es) | 2008-12-05 | 2019-07-11 | Liquidia Tech Inc | Metodo para producir materiales modelados. |
SI2376497T1 (sl) * | 2008-12-12 | 2014-01-31 | Actelion Pharmaceuticals Ltd. | Derivati 5-amino-2-(1-hidroksi-etil)-tetrahidropirana |
US20120114554A1 (en) | 2009-07-13 | 2012-05-10 | Liquidia Technologies, Inc. | Engineered Aerosol Particles, And Associated Methods |
JP5685589B2 (ja) * | 2010-05-25 | 2015-03-18 | 大正製薬株式会社 | 新規な複素環化合物又はその塩 |
CA2840060A1 (en) * | 2011-06-27 | 2013-01-03 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
TW201326180A (zh) * | 2011-11-30 | 2013-07-01 | Actelion Pharmaceuticals Ltd | 3,7-二取代八氫-2H-吡啶并[4,3-e][1,3]□嗪-2-酮抗生素 |
EA029361B1 (ru) | 2013-04-16 | 2018-03-30 | Идорсиа Фармасьютиклз Лтд | Антибактериальные биароматические производные |
UY36851A (es) * | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
-
2016
- 2016-08-12 UY UY0001036851A patent/UY36851A/es not_active Application Discontinuation
- 2016-08-12 TW TW105125824A patent/TW201722965A/zh unknown
- 2016-08-15 EA EA201890412A patent/EA033314B1/ru not_active IP Right Cessation
- 2016-08-15 JP JP2018507672A patent/JP6757402B2/ja not_active Expired - Fee Related
- 2016-08-15 PE PE2018000236A patent/PE20181143A1/es unknown
- 2016-08-15 WO PCT/IB2016/054890 patent/WO2017029602A2/en active Application Filing
- 2016-08-15 KR KR1020187007548A patent/KR20180038046A/ko unknown
- 2016-08-15 CA CA2995715A patent/CA2995715A1/en not_active Abandoned
- 2016-08-15 CN CN201680056596.4A patent/CN108137616B/zh not_active Expired - Fee Related
- 2016-08-15 MX MX2018002033A patent/MX2018002033A/es unknown
- 2016-08-15 CR CR20180111A patent/CR20180111A/es unknown
- 2016-08-15 US US15/752,639 patent/US10364254B2/en not_active Expired - Fee Related
- 2016-08-15 AU AU2016307969A patent/AU2016307969C1/en not_active Ceased
- 2016-08-15 EP EP16788799.1A patent/EP3334739A2/en not_active Withdrawn
- 2016-08-15 MA MA042621A patent/MA42621A/fr unknown
-
2018
- 2018-01-31 IL IL257265A patent/IL257265B/en active IP Right Grant
- 2018-02-02 ZA ZA2018/00722A patent/ZA201800722B/en unknown
- 2018-02-14 CL CL2018000403A patent/CL2018000403A1/es unknown
- 2018-02-15 PH PH12018500358A patent/PH12018500358A1/en unknown
- 2018-02-16 DO DO2018000049A patent/DOP2018000049A/es unknown
- 2018-02-27 CO CONC2018/0002204A patent/CO2018002204A2/es unknown
- 2018-06-25 HK HK18108126.0A patent/HK1248680A1/zh unknown
-
2019
- 2019-01-14 AU AU2019200226A patent/AU2019200226B2/en not_active Ceased
- 2019-05-17 US US16/415,319 patent/US10683307B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018523675A5 (ja) | ||
MX2018005382A (es) | Compuestos de biaril-monobactam y metodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
HRP20190603T1 (hr) | 2-supstituirani spojevi cefema | |
JP2012506871A5 (ja) | ||
JP2011530534A5 (ja) | ||
MX2018010878A (es) | Compuestos de aril-monobactam biciclicos y metodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
IN2014MN01882A (ja) | ||
PH12019500558A1 (en) | Beta-lactamase inhibitor compounds | |
EA202090604A1 (ru) | Хроманмонобактамовые соединения для лечения бактериальных инфекций | |
TW201713633A (en) | Metallo-beta-lactamase inhibitors | |
JP2014051497A5 (ja) | ||
RU2014143821A (ru) | 1, 3, 4-ОКСАДИАЗОЛЬНЫЕ И 1, 3, 4-ТИАДИАЗОЛЬНЫЕ ИНГИБИТОРЫ β-ЛАКТАМАЗЫ | |
HRP20191295T1 (hr) | Kristalne soli amida (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksilne kiseline i postupci uporabe istih | |
JP2017061566A5 (ja) | ||
JP2018531941A5 (ja) | ||
BR112017010132A2 (pt) | terapia combinada para tratamento de infecções bacterianas resistentes | |
BR112014004704A2 (pt) | compostos antibacterianos e métodos de uso | |
NZ740051A (en) | Tetracycline compounds | |
NZ731966A (en) | Novel imaging composition and uses thereof | |
JP2019501896A5 (ja) | ||
EA201890694A1 (ru) | Группа соединений, применяющихся для лечения или предупреждения гиперурикемии или подагры | |
JP2014511366A5 (ja) | ||
JP2020536966A5 (ja) | ||
JP2013532687A5 (ja) | ||
JP2020513808A5 (ja) |